摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

2-氨基-1-(5-氨基-1-苄基-1H-咪唑-4-基)-乙酮 | 71222-43-0

中文名称
2-氨基-1-(5-氨基-1-苄基-1H-咪唑-4-基)-乙酮
中文别名
——
英文名称
2-amino-1-(5-amino-1-benzyl-1H-imidazol-4-yl)-ethanone
英文别名
2-amino-1-(1-benzyl-5-amino-1H-imidazol-4-yl)ethanone;2-Amino-1-[5-amino-1-(phenylmethyl)-1H-imidazol-4-YL] ethanone;2-amino-1-(5-amino-1-benzylimidazol-4-yl)ethanone
2-氨基-1-(5-氨基-1-苄基-1H-咪唑-4-基)-乙酮化学式
CAS
71222-43-0
化学式
C12H14N4O
mdl
MFCD07367978
分子量
230.269
InChiKey
KUYYNLPMBDVZMP-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    0.9
  • 重原子数:
    17
  • 可旋转键数:
    4
  • 环数:
    2.0
  • sp3杂化的碳原子比例:
    0.166
  • 拓扑面积:
    86.9
  • 氢给体数:
    2
  • 氢受体数:
    4

上下游信息

  • 下游产品
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

  • 作为反应物:
    描述:
    4-硝基苯甲酰氯2-氨基-1-(5-氨基-1-苄基-1H-咪唑-4-基)-乙酮三乙胺 作用下, 以 乙腈 为溶剂, 反应 5.0h, 以59%的产率得到3-benzyl-4,5,6,7-tetrahydro-8H-imidazo[4,5-d][1,3]diazepine-5,8-dione
    参考文献:
    名称:
    Ring-expanded nucleosides and nucleotides
    摘要:
    公开号:
    EP1227103B1
  • 作为产物:
    描述:
    2-AMINO-1-[5-AMINO-1-(PHENYLMETHYL)-1H-IMIDAZOL-4-YL] ETHANONE 在 sodium hydroxide 作用下, 以 为溶剂, 以60%的产率得到2-氨基-1-(5-氨基-1-苄基-1H-咪唑-4-基)-乙酮
    参考文献:
    名称:
    Ring-expanded nucleosides and nucleotides
    摘要:
    公开号:
    EP1227103B1
点击查看最新优质反应信息

文献信息

  • Ring expanded nucleosides and nucleotides
    申请人:——
    公开号:US20040077564A1
    公开(公告)日:2004-04-22
    The present invention relates to compositions comprising analogues of purine nucleosides containing a ring-expanded (“fat”) heterocyclic ring, in place of purine, and an unmodified or modified sugar residue, pharmaceutically acceptable derivatives of such compositions, as well as methods of use thereof. In particular, these compositions may be utilized in the treatment of certain cancers, bacterial, fungal, parasitic, and viral infections, including, but not limited to, Acquired Immunodeficiency Syndrome (AIDS), hepatitis, Epstein-Barr and cytomegalovirus.
    本发明涉及含有环扩张(“肥胖”)杂环环代替嘌呤的嘌呤核苷类似物和未经改性或改性的糖残基的组合物,以及这些组合物的药学上可接受的衍生物,以及其使用方法。特别地,这些组合物可用于治疗某些癌症、细菌、真菌、寄生虫和病毒感染,包括但不限于获得性免疫缺陷综合症(AIDS)、肝炎、EB病毒和巨细胞病毒。
  • Irreversible, Tight-Binding Inhibition of Adenosine Deaminase by Coformycins: Inhibitor Structural Features That Contribute to the Mode of Enzyme Inhibition
    作者:Mikyung Hong、Ramachandra S. Hosmane
    DOI:10.1080/07328319708006131
    日期:1997.7
    Coformycin analogues 1-6 were synthesized and biochemically screened against adenosine deaminase in order to assess the relative contributions of N-4, N-6, and the N-3 sugar moiety to the mane of enzyme inhibition. Our results indicate that N-4 plays a relatively greater role than N-6 in enzyme tight-binding, and that a benzyl group can substitute for the sugar moiety at N-3. The absence of a sugar or benzyl group at N-3, however, leads to lass of activity. The hydroxyl group at C-8, while crucial for activity, does not alone confer the tight-binding characteristics to coformycins.
  • RING-EXPANDED NUCLEOSIDES AND NUCLEOTIDES
    申请人:Burns, Barry
    公开号:EP0724587A1
    公开(公告)日:1996-08-07
  • EP0724587A4
    申请人:——
    公开号:EP0724587A4
    公开(公告)日:1996-12-27
  • SYNTHESIS AND MANUFACTURE OF PENTOSTATIN AND ITS PRECURSORS, ANALOGS AND DERIVATIVES
    申请人:Mayne Pharma plc
    公开号:EP1670809B1
    公开(公告)日:2016-01-13
查看更多